VIVEbiotech’s R&D department works in several areas. Therefore, once the desired results are achieved, they can be transferred to the services provided to our customers:
Improve producer cell lines, including the possibility of genetic modification to:
- Enhance productivity.
- Increase tropism.
- Optimize expansion.
- Obtain a stable cell line.
Develop new analytical methods to:
- Better understand our process and/or product.
- Improve analytical methods for batch release.
Different pseudotyping strategies.
Worldwide licensed technology (WO 2015/078999 A1) consisting of a non-integrative episomal stable lentiviral vector that provides a lasting, stable, consistent expression of the transgene in dividing and non-dividing cells.